Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Article in English | MEDLINE | ID: mdl-35722164

ABSTRACT

Sargassum siliquastrum (SS) is an edible brown seaweed widely consumed in Korea and considered a functional food source. Previous studies have reported various biological activities of SS extracts, including antioxidant and hepatoprotective properties. In the present study, we examined the anti-inflammatory effects of the SS extract and assessed the underlying mechanism of action. The SS extract significantly inhibited lipopolysaccharide (LPS)-induced nitric oxide (NO) production in a dose-dependent manner (% of NO production at 500 µg/mL: 60.1 ± 0.9%), with no obvious toxicity. Furthermore, the SS extract inhibited mRNA and protein expression levels of inducible NO synthase, as well as LPS-induced expression and production of proinflammatory cytokines such as IL-1ß, IL-6, or TNF-α (IL-6 production (ng/mL) : LPS-: 0.7 ± 0.3; LPS+: 68.1 ± 2.8; LPS + SS extract: 51.9 ± 1.2; TNF-α production (ng/mL) : LPS-: 0.3 ± 0.1; LPS+: 23.0 ± 0.1; LPS + SS extract: 18.2 ± 10.8). Mechanistically, the SS extract attenuated LPS-induced activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (nuclear factor-kappa B, NF-κB) signaling pathway such as phosphorylation of NF-κB p65 and degradation of IκB-α, thereby blocking LPS-induced activation of NF-κB transcriptional activity. The SS extract also enhanced LPS-induced heme oxygenase-1 expression and attenuated LPS-induced cellular reactive oxygen species production (% of ROS production at 500 µg/mL: 52.2 ± 1.3%). Collectively, these findings suggest that the SS extract elicits anti-inflammatory effects in mouse macrophage cells.

2.
Int J Mol Sci ; 22(21)2021 Oct 25.
Article in English | MEDLINE | ID: mdl-34768930

ABSTRACT

Until now, several studies have looked at the issue of anthocyanin and cancer, namely the preventive and inhibitory effects of anthocyanins, as well as the underlying molecular processes. However, no targeted review is available regarding the anticarcinogenic effects of delphinidin and its glycosides on various cancers and their plausible molecular mechanisms. Considerable evidence shows significant anticancer properties of delphinidin-rich preparations and delphinidin alone both in vitro and in vivo. This review covers the in vitro and preclinical implications of delphinidin-mediated cell protection and cancer prevention; thus, we strongly recommend that delphinidin-rich preparations be further investigated as potential functional food, dietary antioxidant supplements, and natural health products targeting specific chronic diseases, including cancer. In addition to in vitro investigations, future research should focus on more animal and human studies to determine the true potential of delphinidin.


Subject(s)
Anthocyanins/pharmacology , Anticarcinogenic Agents/pharmacology , Antineoplastic Agents/pharmacology , Carcinogenesis/drug effects , Neoplasms/prevention & control , Animals , Anthocyanins/chemistry , Cell Movement/drug effects , Cell Proliferation/drug effects , Dietary Supplements , Glycosides/chemistry , Glycosides/pharmacology , Glycosylation , Humans , Mice , Neoplasms/drug therapy
3.
Molecules ; 25(17)2020 Aug 27.
Article in English | MEDLINE | ID: mdl-32867195

ABSTRACT

Water and ethanol brown macroalgal extracts of nine species of Laminariales and four species of Fucales of the Pacific coast of Russia were investigated. It has been shown that brown algae species of Agarum, Thalassiophyllum, Fucus and Cystoseira can be a source of the polyphenolic compounds with antioxidant activity. Phenolic content in the ethanol algal extracts (Undaria pinnatifida, Arthrothamnus bifidus, Thalassiophyllum clathrus and Agarum turneri) was 1.1-3.5 times higher than in the water extracts. In Sargassum pallidum and Kjellmaniella crassifolia, the total polyphenolic content was 2.1 and 1.6 times higher, respectively, in water extracts than in ethanol extracts. The maximum radical scavenging activity has been detected in Agarum turneri ethanol extracts (38.8 mg ascorbic acid/g and 2506.8 µmol Trolox equiv/g dry algae). Phlorotannin content varies from 16.8 µg/g dry sample of Costaria costata to 2763.2 µg/g dry sample of Agarum turneri. It is found the content of polyphenolic compounds in brown algae is determined mainly by their species-specificity and by their belonging to the genus. The presence of major phenols in the extract of Thalassiophyllum clathrus, such as phenolic acid (gallic acid), hydroxycinnamic acids (caffeic acid, chlorogenic acid, coumaric acid) and flavonols (kaempferol, quercetin) has been established.


Subject(s)
Antioxidants/analysis , Phaeophyceae/chemistry , Phenols/analysis , Pacific Ocean , Russia
4.
Appl Microbiol Biotechnol ; 104(2): 799-816, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31820066

ABSTRACT

Pseudomonas aeruginosa is known as an opportunistic pathogen whose one of the antibiotic resistance mechanisms includes biofilm formation and virulence factor production. The present study showed that the sub-minimum inhibitory concentration (sub-MIC) of streptomycin inhibited the formation of biofilm and eradicated the established mature biofilm. Streptomycin at sub-MIC was also capable of inhibiting biofilm formation on the urinary catheters. In addition, the sub-MIC of streptomycin attenuated the bacterial virulence properties as confirmed by both phenotypic and gene expression studies. The optimal conditions for streptomycin to perform anti-biofilm and anti-virulence activities were proposed as alkaline TSB media (pH 7.9) at 35 °C. However, sub-MIC of streptomycin also exhibited a comparative anti-biofilm efficacy in LB media at similar pH level and temperature. Furthermore, this condition also improved the biofilm inhibition and eradication properties of streptomycin, tobramycin and tetracycline towards the biofilm formed by a clinical isolate of P. aeruginosa. Findings from the present study provide an important insight for further studies on the mechanisms of biofilm inhibition and dispersion of pre-existing biofilm by streptomycin as well as tobramycin and tetracycline under a specific culture environment.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Biofilms/growth & development , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Streptomycin/pharmacology , Virulence/drug effects , Catheters/microbiology , Culture Media/chemistry , Gene Expression Profiling , Hydrogen-Ion Concentration , Temperature , Tetracycline/pharmacology , Tobramycin/pharmacology , Virulence Factors/biosynthesis
5.
Mar Drugs ; 17(2)2019 Feb 25.
Article in English | MEDLINE | ID: mdl-30823522

ABSTRACT

Enhanced oxidative stress plays a central role in promoting endothelial dysfunction, leading to the development of atherosclerosis. In this study, we investigated the protective effects of the hydrolysates derived from blue mussel (Mytilus edulis) against H2O2-mediated oxidative injury in human umbilical vein endothelial cells (HUVECs). The blue mussel hydrolysates were prepared by enzymatic hydrolysis with eight proteases, and blue mussel-α-chymotrypsin hydrolysate (BMCH) showed the highest antioxidant activities in DPPH radical scavenging, ABTS⁺ radical scavenging, and ORAC value compared to those of the other hydrolysates. BMCH also inhibited Cu2+-mediated low density lipoprotein (LDL) oxidation. Treatment of H2O2 resulted in the decreased HUVEC viability whereas pre-treatment with BMCH increased HUVEC viability and reduced reactive oxygen species (ROS) generation. BMCH pre-treatment increased cellular antioxidant capacities, including levels of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) against H2O2-mediated oxidative stress in HUVECs. Flow cytometry and western blot analysis revealed that BMCH pre-treatment significantly reduced H2O2-mediated HUVEC apoptosis through inhibition of caspase-3 activation. Real-time-qPCR analysis showed that BMCH down-regulated expression of p53 and caspase-3 genes, as well as decreased the bax/bcl-2 ratio. Taken together, these results indicate that BMCH may be useful as functional food ingredients for protecting endothelial dysfunction or related disease.


Subject(s)
Amino Acids/chemistry , Caspase 3/metabolism , Human Umbilical Vein Endothelial Cells/drug effects , Mytilus edulis/chemistry , Oxidative Stress/drug effects , Protein Hydrolysates/pharmacology , Amino Acids/metabolism , Amino Acids/pharmacology , Animals , Antioxidants/chemistry , Antioxidants/isolation & purification , Antioxidants/pharmacology , Apoptosis/drug effects , Enzyme Activation/drug effects , Glutathione/metabolism , Human Umbilical Vein Endothelial Cells/pathology , Humans , Hydrogen Peroxide/administration & dosage , Lipoproteins, LDL/metabolism , Mytilus edulis/metabolism , Protein Hydrolysates/chemistry , Protein Hydrolysates/isolation & purification , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger , Reactive Oxygen Species/metabolism , Tumor Suppressor Protein p53/metabolism , bcl-2-Associated X Protein/metabolism
6.
Biomed Pharmacother ; 108: 103-110, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30218854

ABSTRACT

Oxidative stress-mediated endothelial dysfunction and LDL oxidation have been implicated in the pathogenesis of atherosclerosis. Thus, the protection of the endothelial cells against oxidative stress-mediated injury and the inhibition of LDL oxidation by the use of antioxidants are a good strategy against atherosclerosis development. Here, we investigated the protective effect and the inhibition of LDL oxidation of seahorse H. abdominalia hydrolysates by Alcalase (SHAH). SHAH showed higher antioxidant activities by measuring DPPH, ABTS+, and ORAC assays than the other hydrolysates. SHAH reduced the formation of thiobarbituric acid reactive substance in Cu2+-induced LDL oxidation. In human umbilical vein endothelial cell (HUVEC), SHAH ameliorated H2O2-mediated HUVEC injury through the restoration of antioxidant enzyme activities and glutathione. In addition, SHAH inhibited HUVEC apoptosis through the down-regulation of caspase-3 and p53 and the increase bcl-2/bax ratio. These results suggested that seahorse H. abdominalia could be developed as potential agents for atherosclerosis.


Subject(s)
Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/pathology , Hydrogen Peroxide/toxicity , Protective Agents/pharmacology , Protein Hydrolysates/pharmacology , Smegmamorpha/metabolism , Amino Acids/analysis , Animals , Antioxidants/pharmacology , Apoptosis/drug effects , Catalase/metabolism , Cell Proliferation/drug effects , Cytoprotection/drug effects , Gene Expression Regulation/drug effects , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Humans , Lipoproteins, LDL/metabolism , Molecular Weight , Oxidation-Reduction , Oxidative Stress/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Superoxide Dismutase/metabolism
7.
Mitochondrial DNA B Resour ; 3(2): 586-587, 2018 May 15.
Article in English | MEDLINE | ID: mdl-33474252

ABSTRACT

We sequenced the complete mitochondrial (mt) genome of Gavia arctica. The circular mt genome is 17,065 bp long, consisting of 37 genes (13 proteins, 22 transfer RNAs, and two ribosomal RNAs) and a control region. Phylogenetic analysis based on the full mt genome sequences confirmed that the genus Gavia is a monophyletic group, containing the G. stellata, G. arctica, and G. pacifica. These data can provide insights into the phylogenetic relationships for inferring the pattern and degree of mt genome evolution among the loon species.

8.
Inflammation ; 35(2): 736-45, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21845471

ABSTRACT

Extracellular matrix-degrading protease, matrix metalloproteinase-9 (MMP-9), is known to be involved in vascular smooth muscle cell (SMC)'s aberrant proliferation and movement in atherosclerotic lesions. During screening of the MMP-9-inhibitory compounds from marine animal resources, we have found that the ethyl acetate extract from Cliona celata (ECC) effectively inhibits the SMC-derived MMP-9 enzyme activity and gene expression. In addition, the ECC effectively repressed the migration potential of the tumor necrosis factor-α (TNF-α)-stimulated human aortic smooth muscle cell (HASMC). As assessed by Western blot analysis, the produced MMP-9 protein levels in the TNF-α-induced HASMC were significantly decreased by the concomitant treatment of ECC at the 50- to 300-µg/mL concentration ranges. In addition, in the RT-PCR experiment, the expressed MMP-9 mRNA levels in the TNF-α-induced HASMC were seemingly decreased by ECC treatment at the same concentration ranges (50-300 µg/mL). For the action mechanism(s) of ECC to the phenotype changes in HASMC, we have further evaluated the ECC's pharmacological activities on the signal molecules which are importantly linked in the MMP-9 expression and cell migration potential of HASMC. We have found that extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation as a target point is suppressed by the ECC treatment in the TNF-α-treated HASMC. Using electrophoretic mobility shift assay, the nuclear extracts purified from ECC-treated HASMCs were shown to decrease the binding potentials on the labeled nuclear factor-kappaB (NF-κB) and activator protein 1 probes. NF-κB p65 and phosphorylated c-Jun contents were also decreased in the purified nuclear extracts from the ECC-treated HASMC, as confirmed by Western blot analysis. Finally, it was shown that the ECC-treated HASMCs were less migrated when compared to the TNF-α-treated cells, as confirmed by HASMC migration assays using the 8-µm pore transwell membranes. From these results, it was proposed that ECC has a potentially applicable anti-atherosclerotic activity.


Subject(s)
Matrix Metalloproteinase 9/metabolism , NF-kappa B/metabolism , Porifera , Transcription Factor AP-1/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Down-Regulation , Electrophoretic Mobility Shift Assay , Humans , JNK Mitogen-Activated Protein Kinases/metabolism , MAP Kinase Signaling System/drug effects , Matrix Metalloproteinase Inhibitors , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/metabolism , Phosphorylation/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription Factor RelA/metabolism , Tumor Necrosis Factor-alpha/metabolism
9.
Carbohydr Res ; 345(8): 1065-7, 2010 May 27.
Article in English | MEDLINE | ID: mdl-20381795

ABSTRACT

Waxy maize starch (100% amylopectin) granules were modified by reaction of the granules with glucoamylase in a minimum amount of water to give 29% (w/w) D-glucose inside the granules [Kim, Y.-K.; Robyt, J. F. Carbohydr. Res.1999, 318, 129-134]. These granules were made into beads by dropping an ethanol slurry of starch and different amounts of Eudragit L100-55 in a constant ratio of 100:1 from a pipette onto Whatman 3MM filter paper. The starch beads were air dried and then repeatedly sprayed 0-12 times with 2.0% (w/v) Eudragit L100-55 in ethanol, with drying between each spraying, to coat the surface of the starch beads, giving different amounts of Eudragit L100-55 coating. Seven different kinds of beads, with different amounts of Eudragit L100-55 binding and coating agent, were obtained. The rates of release of D-glucose into water from the seven kinds of beads were inversely proportional to the amount of binding and coating agent. Bead type I, which was without any binding and coating gave a fast 100% release of D-glucose in 30 min. Beads II and III also gave a fast 100% release in 60 min and 90 min, respectively. Bead IV gave a near linear release of 97% D-glucose in 150 min; Bead V gave a 50% release in 120 min followed by the remaining 50% in 60 min; and Beads VI and VII gave a slow release of 10% and 4%, respectively, from 0 to 120 min, followed by a rapid 100% release from 120 to 180 min.


Subject(s)
Acrylic Resins/chemistry , Glucose/chemistry , Glucose/metabolism , Starch/metabolism , Starch/chemistry , alpha-Amylases/metabolism
10.
Environ Toxicol Pharmacol ; 26(1): 61-7, 2008 Jul.
Article in English | MEDLINE | ID: mdl-21783889

ABSTRACT

We investigated mechanism(s) where propolis induces apoptosis in human leukemic U937 cells. Propolis inhibited the proliferation of U937 cells in a dose-dependent manner by inducing apoptosis and blocking cell cycle progression in the G2/M phase. Western blot analysis showed that propolis increases the expression of p21 and p27 proteins, and decreases the levels of cyclin B1, cyclin A, Cdk2 and Cdc2, thereby contributing to cell cycle arrest. DAPI staining assay revealed typical morphology features of apoptotic cells. Propolis-induced apoptosis was also confirmed by assays with annexin V-FITC, PI-labeling and DNA fragmentation assay. The increase in apoptosis level induced by propolis was associated with down-regulation of Bcl-2 and activation of caspase-3, but not with Bax. These results suggests that propolis-induced apoptosis is related to the selective activation of caspase-3 and induction of Bcl-2/Bax regulation.

11.
Int J Biochem Cell Biol ; 37(2): 375-85, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15474982

ABSTRACT

Prostaglandin E2 (PGE2), an abundant eicosanoid in bone, has been implicated in a number of pathological states associated with bone loss, and is also known to stimulate matrix metalloproteinase (MMP)-1 synthesis and secretion in rat and human osteoblast cells, although the nature of the intracellular reaction remains unclear. Although MMP-1 plays a critical role in bone-remodeling, it would be of interest to examine whether PGE2 regulates MMP-1 expression by mouse osteoblasts or not. Here we demonstrate that PGE2 is a potent inducer of MMP-1 production in fetal osteoblasts and show that PGE2 stimulates the activity of the MMP-1 promoter in osteoblasts, suggesting that PGE2 controls MMP-1 gene expression at least at the transcriptional level. PGE2 induced MMP-1 messenger RNA (mRNA) expression in the cells within 4 h, and this expression was maintained for 36 h. The increase in MMP-1 production with 0.1-2.0 microM PGE2 was dose-dependent. We also found that PGE2 (1.5 microM) up-regulated MMP-1 protein levels in cultured mouse osteoblasts, as evidenced by ELISA. To examine whether PGE2 mediated response and signal pathway are involved in the intracellular action, the PGE2-mediated expression of the MMP-1 gene was investigated in mouse osteoblast cells. A Northern blot analysis showed that PGE2 and PGE1 were potent stimulators of MMP-1 transcription, and the presence of thromboxane B2 had no effect. The increase in MMP-1 transcript after PGE2 treatment was observed at 4h, reaching a maximum at 6h, and persisted for 24h. This response was dose-dependent. Cycloheximide, an inhibitor of protein synthesis, completely blocked this effect by PGE2, indicating that the expression of other genes is also required. The second messenger analog, 8-bromo-cAMP, mimicked the effects of PGE2 by stimulating a dose-dependent increase in MMP-1 mRNA levels, with a maximal effect that was quantitatively similar to that observed with PGE2. Thus, the present results strongly suggest that the PGE2 stimulation of MMP-1 synthesis is due to the activation of MMP-1 gene transcription and a subsequent marked increase in MMP-1 transcription. This effect is dependent on de novo protein synthesis and is mimicked by protein kinase A activation. The findings suggest that PGE2 is involved in the cAMP-PKA signaling pathway in regulating MMP-1 gene expression in osteoblasts.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Dinoprostone/pharmacology , Matrix Metalloproteinase 1/biosynthesis , Osteoblasts/metabolism , Oxytocics/pharmacology , Second Messenger Systems/drug effects , Animals , Cells, Cultured , Dose-Response Relationship, Drug , Gene Expression Regulation, Enzymologic/drug effects , Matrix Metalloproteinase 1/genetics , Mice , Mice, Inbred BALB C , Promoter Regions, Genetic/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Transcription, Genetic/drug effects , Transcription, Genetic/genetics
12.
J Cell Physiol ; 203(3): 493-500, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15605368

ABSTRACT

Dietary isothiocyanates (ITCs) have shown protective effects against certain chemically induced cancers in animal models. These inhibitory effects are associated with reduced levels of extracellular signal-regulated kinase (ERK) 1/2 activity and the arrest of the G(1) cell cycle. Benzyl isothiocyanate (BITC) treatment down-regulates cyclins and CDKs and up-regulates the expression of the CDK inhibitor p21, but up-regulation of p27 or p53 was not detected. Since antiatherogenic effects are not needed for antiproliferation, we determined whether BITC exerted inhibitory effects on matrix metalloproteinase-9 (MMP-9) activity in TNF-alpha-induced vascular smooth muscle cells (VSMCs). BITC inhibited TNF-alpha-induced MMP-9 secretion in VSMC in a dose dependent manner. This inhibition was characterized by the down-regulation of MMP-9, which is transcriptionally regulated at the NF-kappaB site, and the activation protein-1 (AP-1) site in the MMP-9 promoter. These findings indicate that BITC is an effective agent for inhibiting cell proliferation, the G1 to S phase cell cycle progress, and MMP-9 expression through the transcription factors NF-kappaB and AP-1 in TNF-alpha-induced VSMC.


Subject(s)
Cell Cycle Proteins/drug effects , Extracellular Signal-Regulated MAP Kinases/drug effects , Isothiocyanates/pharmacology , Matrix Metalloproteinase 9/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/enzymology , Animals , Antineoplastic Agents/pharmacology , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Cycle Proteins/metabolism , Cell Proliferation/drug effects , Cyclin-Dependent Kinases/drug effects , Cyclin-Dependent Kinases/metabolism , Cyclins/drug effects , Cyclins/metabolism , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Down-Regulation/physiology , Extracellular Signal-Regulated MAP Kinases/metabolism , Growth Inhibitors/pharmacology , Humans , Matrix Metalloproteinase 9/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , Transcription Factor AP-1/drug effects , Transcription Factor AP-1/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/metabolism
13.
Phytother Res ; 18(6): 488-93, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15287076

ABSTRACT

The Paeng-Jo-Yeon-Nyeon-Baek-Ja-In-Hwan (PJBH) prescription is a dried decoctum consisting of a mixture of 18 medicinal herbs that include Semen Biotae, Fructus Torilis seu cnidii, Fructus Rubi, Herba Dendrobii, Radix Morindae officinalis, Cortex Eucommiae, Radix Aspragi, Radix Polygalae, Radix Dipsaci, Ramulus Cinnamomi, Rhizoma Acori graminei, Rhizoma Alismatis, Rhizoma Dioscoreae, Radix Ginseng, Radix Rehmanniae preparata, Fructus corni, Fructus Schisandrae and Herba Cistanches. The effect of PJBH extracts on H2O2-induced toxicity in the rat pheochromocytoma line PC12 was examined by measurements of cell lesion, level of lipid peroxidation and antioxidant enzyme activities, since free radicals are involved in neurodegeneration in Alzheimer's disease (AD). After a 30 min exposure of the cells to H2O2 (150 microM), a marked decrease in cell survival, activities of glutathione peroxidase and catalase as well as an increased production of malondialdehyde (MDA) were found. Pretreatment of the cells with PJBH (0.5-10 microg/ml) prior to H2O2 exposure significantly elevated cell survival, antioxidant enzyme activities and resulted in a decrease in the level of MDA. The effects of the PJBH on hydrogen peroxide-induced injury in PC12 cells were also examined. PJBH had a remarkable elevating effect on catalase and GSH-Px activities as well as cell survival, suggesting that cytoprotective effects of the PJBH are involved in stimulation against intermediate concentrations of H2O2-induced PC12 cell injury. The above-mentioned neuroprotective effects were also compared with the effect of tacrine. The results suggest that PJBH has potential for use as a novel neuronal therapeutic agent.


Subject(s)
Alzheimer Disease/prevention & control , Cholinesterase Inhibitors/pharmacology , Drugs, Chinese Herbal/pharmacology , Phytotherapy , Plants, Medicinal , Animals , Cell Survival/drug effects , Cholinesterase Inhibitors/administration & dosage , Cholinesterase Inhibitors/therapeutic use , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/therapeutic use , Fruit , Glutathione Peroxidase/metabolism , Humans , Hydrogen Peroxide , Korea , Medicine, Traditional , PC12 Cells/drug effects , PC12 Cells/enzymology , PC12 Cells/metabolism , PC12 Cells/pathology , Plant Leaves , Plant Roots , Plant Stems , Rats , Rhizome , Seeds
14.
Carbohydr Res ; 339(6): 1179-84, 2004 Apr 28.
Article in English | MEDLINE | ID: mdl-15063208

ABSTRACT

A novel intracellular cycloalternan-degrading enzyme (CADE) was purified to homogeneity from the cell pellet of Bacillus sp. NRRL B-21195. The enzyme has a molecular mass of 125 kDa on SDS-PAGE. The pH optimum was 7.0, and the enzyme was stable from pH 6.0 to 9.2. The temperature optimum was 35 degrees C and the enzyme exhibited stability up to 50 degrees C. The enzyme hydrolyzed cycloalternan [CA; cyclo(-->6)-alpha-d-Glcp-(1-->3)-alpha-d-Glcp-(1-->6)-alpha-d-Glcp-(-->3)-alpha-d-Glcp-(1-->)] as the best substrate, to produce only isomaltose via an intermediate, alpha-isomaltosyl-(1-->3)-isomaltose. This enzyme also hydrolyzed isomaltosyl substrates, such as panose, alpha-isomaltosyl-(1-->4)-maltooligosaccharides, alpha-isomaltosyl-(1-->3)-glucose, and alpha-isomaltosyl-(1-->3)-isomaltose to liberate isomaltose. Neither maltooligosaccharides nor isomaltooligosaccharides were hydrolyzed by the enzyme, indicating that CADE requires alpha-isomaltosyl residues connected with (1-->4)- or (1-->3)-linkages. The K(m) value of cycloalternan (1.68 mM) was 20% of that of panose (8.23 mM). The k(cat) value on panose (14.4s(-1)) was not significantly different from that of cycloalternan (10.8 s(-1)). Judging from its specificity, the systematic name of the enzyme should be cycloalternan isomaltosylhydrolase. This intracellular enzyme is apparently involved in the metabolism of starch via cycloalternan in Bacillus sp. NRRL B-21195, its role being to hydrolyze cycloalternan inside the cells.


Subject(s)
Bacillus/enzymology , Glucosidases/chemistry , Glucosidases/isolation & purification , Oligosaccharides/metabolism , Carbohydrate Conformation , Electrophoresis, Polyacrylamide Gel , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Models, Chemical , Oligosaccharides/chemistry , Substrate Specificity , Temperature , Time Factors
15.
Carbohydr Res ; 338(21): 2213-20, 2003 Oct 10.
Article in English | MEDLINE | ID: mdl-14553982

ABSTRACT

Cycloalternan-forming enzyme (CAFE) was first described as the enzyme that produced cycloalternan from alternan. In this study, we found that a partially purified preparation of CAFE containing two proteins catalyzed the synthesis of cycloalternan from maltooligosaccharides, whereas the purified CAFE alone was unable to do so. In addition to the 117 kDa CAFE itself, the mixture also contained a 140 kDa protein. The latter was found to be a disproportionating enzyme (DE) that catalyzes transfer of a D-glucopyranosyl residue from the non-reducing end of one maltooligosaccharide to the non-reducing end of another, forming an isomaltosyl residue at the non-reducing end. CAFE then transfers the isomaltosyl residue to the non-reducing end of another isomaltosyl maltooligosaccharide, to form an alpha-isomaltosyl-(1-->3)-alpha-isomaltosyl-(1-->4)-maltooligosaccharide, and subsequently catalyzes a cyclization to produce cycloalternan. Thus, DE and CAFE act synergistically to produce cycloalternan directly from maltodextrin or starch.


Subject(s)
Bacillus/enzymology , Glucosyltransferases/metabolism , Glycogen Debranching Enzyme System/metabolism , Glycoside Hydrolases/metabolism , Oligosaccharides/metabolism , Carbohydrate Sequence , Catalysis , Cyclization , Glucosyltransferases/chemistry , Glucosyltransferases/isolation & purification , Glycogen Debranching Enzyme System/chemistry , Glycogen Debranching Enzyme System/isolation & purification , Glycoside Hydrolases/chemistry , Glycoside Hydrolases/isolation & purification , Molecular Sequence Data , Oligosaccharides/chemistry , Polysaccharides/metabolism , Starch/metabolism
16.
Carbohydr Res ; 338(19): 1981-90, 2003 Sep 10.
Article in English | MEDLINE | ID: mdl-14499574

ABSTRACT

Enzymatic synthesis was attempted of six trisaccharides and 14 tetrasaccharides comprising beta-(1-->4)-linked D-glucose and D-xylose residues, using cellodextrin phosphorylase (CDP, EC 2.4.1.49) as the enzyme catalyst, with alpha-D-glucose 1-phosphate (1) or alpha-D-xylose 1-phosphate (2) as the donor substrates, and cellobiose (3), xylobiose (4), betaGlc-(1-->4)-Xyl (5), or betaXyl-(1-->4)-Glc (6) as the acceptor substrates. All enzymatic reactions were performed at pH 7.0 and the products purified by gel-filtration chromatography. We successfully synthesized all six hetero-trisaccharides and 10 of the 14 possible hetero-tetrasaccharides. It was not found possible to synthesize the four tetrasaccharides with a Xyl-->Glc sequence at their non-reducing ends employing this method. The stereochemistries of the isolated products were assessed by analysis of their 2D NMR spectra (DQF-COSY, TOCSY, HSQC, HMBC), confirming that all of the glycosidic bonds in the products were beta-(1-->4) linkages.


Subject(s)
Glucose/metabolism , Glucosyltransferases/metabolism , Oligosaccharides/biosynthesis , Oligosaccharides/chemistry , Xylose/metabolism , Carbohydrate Sequence , Carbon Isotopes , Chromatography, Gel , Chromatography, Thin Layer , Glucose/chemistry , Magnetic Resonance Spectroscopy , Molecular Sequence Data , Stereoisomerism , Tritium , Xylose/chemistry
17.
Immunol Invest ; 32(3): 171-86, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12916707

ABSTRACT

Bone cells produce multiple growth factors and cytokines that have effects on bone metabolism and can be incorporated into the bone matrix. The present study was designed to extend these observations by examining the interactions between transforming growth factor-beta (TGF-beta) or interleukin-1beta (IL-1beta) and bone cells in a rat long bone culture model. IL-1beta regulates several activities of the osteoblast cells derived from rat long bone explants in vitro. IL-1beta stimulated cellular proliferation and the synthesis of prostaglandin E2 and plasminogen activator activity in the cultured cells in a dose-dependent manner. TGF-B is present in the bone matrix and potentially can be released during bone resorption. TGF-beta reduced basal bone resorption and inhibited vitamin D3 [1,25(OH)2D3]-induced bone resorption in rat long bone cells. These studies support the role of IL-1beta in the pathological modulation of bone cell metabolism, with regard to implication in the pathogenesis of osteoporosis by IL-1beta, and that TGF-beta is positively inhibiting the bone resorption.


Subject(s)
Bone Resorption/metabolism , Interleukin-1/physiology , Osteoblasts/metabolism , Transforming Growth Factor beta/physiology , Alkaline Phosphatase/metabolism , Animals , Bone Resorption/chemically induced , Calcitriol/pharmacology , Cells, Cultured , Dinoprostone/biosynthesis , Dose-Response Relationship, Drug , Interleukin-1/pharmacology , Mice , Osteoblasts/drug effects , Plasminogen Activators/metabolism , Skull/cytology , Transforming Growth Factor beta/pharmacology
18.
J Ethnopharmacol ; 87(2-3): 149-54, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12860300

ABSTRACT

Prunus persica L. BATSCH seed-water extract (PPE) has been used in the treatment of the degenerative disorders, such as hypermenorrhea and dysmenorrhea, in Taiwan, China, Japan and Korea. In this study, the effects of oral administration of PPE on the extracellular acetylcholine concentration in the hippocampus of rats were evaluated, and compared to that of tacrine (9-amino-1,2,3,4-tetrahydroacridine hydrochloride), a well-known and centrally acting acetylcholinesterase (AChE) inhibitor, which had been developed for the treatment of Alzheimer's disease. We measured the inhibition of brain AChE. PPE at 2.5g/kg and tacrine at 5mg/kg showed significant effects for more than 6h. At these doses, the maximum increases were observed at about 1.5h after administration of PPE, and at about 2h with tacrine, and were 454 and 412% of the pre-level, respectively. The results suggest that oral administration of PPE and tacrine increases acetylcholine concentration in the synaptic cleft of the hippocampus mostly through AChE inhibition, and that PPE has a potent and long-lasting effect on the central cholinergic system.


Subject(s)
Acetylcholine/metabolism , Cholinesterase Inhibitors/pharmacology , Hippocampus/drug effects , Prunus/chemistry , Tacrine/pharmacology , Acetylcholinesterase/metabolism , Administration, Oral , Animals , Cholinesterase Inhibitors/metabolism , Hippocampus/metabolism , Male , Microdialysis , Plant Extracts/chemistry , Plant Extracts/metabolism , Plant Extracts/pharmacology , Rats , Rats, Wistar , Tacrine/metabolism , Time Factors , Water
19.
Int Immunopharmacol ; 3(7): 1001-10, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12810357

ABSTRACT

Water extract of deer antler aqua-acupunture (DAA) prepared from the growing antler of Cervus korean TEMMINCK var. mantchuricus Swinhoe, was used to investigate the efficacy of a traditional immunosuppressive and immuno-activating Korean aqua-acupuncture, on the development of type II collagen (CII)-induced arthritis (CIA) in rats. The onset of arthritis was observed at the 24th day after the CII-immunization in rats, and the severity of CIA was gradually developed. As compared with rats treated with saline, DAA i.p. injected at doses of more than 50 microg/kg once a day for 14 days inhibited the ability of inguinal lymph node cells to produce T cell cytokines interleukin 2 and interferon-gamma when the cells were obtained from rats 24 days after immunization and cultured in vitro with CII. Treatment with DAA also inhibited the production of macrophage cytokines interleukin-1beta, IL-6 and tumor necrosis factor alpha in response to in vitro stimulation of lymph node and macrophage cells with CII. In addition, in order to evaluate the influence of DAA on the incidence and development of arthritis in rat CIA, rats were immunized twice at a 3-week interval with bovine CII, with DAA being given i.p. once a day for 14 days with four different regimens. A 14-day course of DAA treatment at a daily dose of 100 microg/kg, which began on the day of the first CII immunization, suppressed the development of arthritis, as well as antibody formation and delayed-type hypersensitivity to CII. Treatment with DAA, which started on the same day as the booster immunization, also resulted in inhibition of development of arthritis and of immune responses to CII. However, treatment with DAA, which was prophylactically started prior to a primary immunization, did not inhibit the development of arthritis and immune response to CII. Furthermore, DAA extract did not affect the established diseases.


Subject(s)
Acupuncture , Antlers/chemistry , Arthritis, Experimental/prevention & control , Tissue Extracts/pharmacology , Animals , Arthritis, Experimental/immunology , Arthritis, Experimental/metabolism , Cell Division , Collagen/immunology , Cytokines/biosynthesis , Deer , Hemagglutination Tests , Hypersensitivity, Delayed/immunology , In Vitro Techniques , Injections, Intraperitoneal , Lymph Nodes/immunology , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphocyte Activation/drug effects , Mice , Mice, Inbred DBA , Rats , Sheep , Tissue Extracts/isolation & purification , Tissue Extracts/therapeutic use , Water
20.
Int Immunopharmacol ; 3(5): 723-34, 2003 May.
Article in English | MEDLINE | ID: mdl-12757741

ABSTRACT

Geiji-Bokryung-Hwan (GBH), a drug preparation consisting of five herbs of Cinnamomi Ramulus (Geiji), Poria Cocos (Bokryun), Mountan Cortex Radicis (Mokdanpi), Paeoniae Radix (Jakyak) and Persicae Semen (Doin), is a traditional Korean herbal medicine that is widely used in the treatment of atherosclerosis-related disorders. A water extract of GBH was found to scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals and inhibit low-density lipoprotein (LDL) oxidation more effectively than probucol, a well-known commercially available antioxidant. In order to evaluate the anti-atherogenic potential of this medication, New Zealand White (NZW) rabbits were fed a normal diet for 12 weeks, a high cholesterol diet, a high cholesterol diet containing 1% probucol or a high cholesterol diet containing 5% water-soluble extract of GBH. Both GBH and probucol reduced plasma cholesterol levels. LDLs from the GBH-treated group were more resistant to Cu(2+)-induced oxidation and contained more vitamin E than LDLs from the high cholesterol diet group. Endothelial damage, determined at week 6, was reduced by 55% in the GBH group (P<0.01). GBH treatment reduced an atherosclerotic area in the abdominal aorta by 58% (P<0.05) and cholesterol deposition in the thoracic aorta by 55% (P<0.05). The severity of atherosclerosis in the GBH group was significantly reduced after an adjustment using cholesterol exposure as an index of the cholesterol-lowering effect. On the other hand, diet-induced hyperlipidemic rabbits were given water extract of GBH in doses of 50 (Group B) and 200 mg/kg (Group C) and compared with controls (Group A). At 40 days after intervention in groups A, B and C, total and LDL cholesterol levels were significantly lowered (P<0.01). LDL/high density lipoprotein (HDL) ratio was also significantly decreased (P<0.01). This study concludes that the reduction in atherosclerosis by GBH relies not only on its cholesterol-lowering effect but also more heavily on its antioxidant potential, which prevents endothelial damage and inhibits LDL oxidative modification in hypercholesterolemic animals.


Subject(s)
Anticholesteremic Agents/therapeutic use , Arteriosclerosis/drug therapy , Cholesterol, Dietary , Hypercholesterolemia/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Animals , Arteriosclerosis/blood , Arteriosclerosis/pathology , Biphenyl Compounds , Cholesterol, LDL/blood , Endothelium, Vascular/pathology , Free Radical Scavengers/pharmacology , Hypercholesterolemia/blood , Hypercholesterolemia/pathology , Lipoproteins/metabolism , Male , Oxidation-Reduction , Picrates/metabolism , Rabbits , Vitamin E/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...